Stockscreener 앱 받기
132.63
4.86%
-6.77
시간 외 거래:
132.63
Repligen Corp 주식(RGEN)의 최신 뉴스
Impax Asset Management Group plc Reduces Position in Repligen Corporation $RGEN - MarketBeat
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Bessemer Group Inc. Sells 238,450 Shares of Repligen Corporation $RGEN - Defense World
Repligen (NASDAQ:RGEN) Upgraded to "Buy" at Wall Street Zen - MarketBeat
What Makes Repligen Corporation (RGEN) an Investment Choice? - Yahoo Finance
Repligen is Now Oversold (RGEN) - Nasdaq
A Look At Repligen (RGEN) Valuation As Ordering Stabilizes And Growth Segments Progress - Yahoo Finance
Repligen Corp (RGEN) Stock Price Down 3.37% on Jan 29 - GuruFocus
Head-To-Head Comparison: Repligen (NASDAQ:RGEN) vs. Abpro (NASDAQ:ABP) - Defense World
3 Reasons to Sell RGEN and 1 Stock to Buy Instead - Finviz
Pharma News: Can Repligen Corporation navigate macro headwindsMarket Sentiment Review & Safe Entry Point Identification - mfd.ru
UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds - Insider Monkey
Repligen Corporation (NASDAQ:RGEN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Repligen Corp (RGEN) Shares Up 3.89% on Jan 21 - GuruFocus
Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica - GlobeNewswire Inc.
Slow Capital Inc. Has $5.89 Million Holdings in Repligen Corporation $RGEN - MarketBeat
Is It Too Late To Consider Buying Repligen Corporation (NASDAQ:RGEN)? - Yahoo Finance
Stephens Investment Management Group LLC Grows Stock Position in Repligen Corporation $RGEN - MarketBeat
Expert Outlook: Repligen Through The Eyes Of 5 Analysts - Benzinga
UBS raises Repligen stock price target to $200 on bioprocessing recovery - Investing.com
Why Repligen (RGEN) Shares Are Sliding Today - Finviz
Repligen Corp. Seeks M&A Opportunities - marketscreener.com
Published on: 2026-01-13 17:35:09 - Bộ Nội Vụ
Conestoga Capital Advisors LLC Has $127.91 Million Position in Repligen Corporation $RGEN - Defense World
Is Repligen Corporation stock gaining market share2025 Volatility Report & Growth Oriented Trading Recommendations - ulpravda.ru
Can Repligen Corporation stock hit record highs againJuly 2025 Levels & AI Powered Market Trend Analysis - Улправда
Repligen appoints Madaus as new board chair, Hunt to retire By Investing.com - Investing.com Canada
Repligen appoints Madaus as new board chair, Hunt to retire - Investing.com
Repligen Corporation Elects Dr. Martin D. Madaus as New Chair of the Board, Succeeding Tony Hunt - Quiver Quantitative
Repligen Corp Announces New Chair of the Board - TradingView — Track All Markets
Longtime Repligen leader steps down as new board chair takes over in 2026 - Stock Titan
Repligen Corporation (RGEN): Investor Outlook with a 15% Upside Potential in the Bioprocessing Sector - DirectorsTalk Interviews
Institution Moves: How risky is Repligen Corporation RGN stock compared to peersMarket Risk Report & Risk Controlled Stock Pick Alerts - Bộ Nội Vụ
About Us - FinancialContent
Pacer Advisors Inc. Has $1.37 Million Position in Repligen Corporation $RGEN - MarketBeat
Allspring Global Investments Holdings LLC Lowers Stake in Repligen Corporation $RGEN - MarketBeat
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - Business Wire
Delta Investment Management LLC Buys Shares of 50,717 Repligen Corporation $RGEN - MarketBeat
Repligen Corporation (NASDAQ:RGEN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Why Repligen Corporation stock remains undervaluedFibonacci Retracement Levels & Free Dynamic Capital Growth - bollywoodhelpline.com
Is Repligen (RGEN) Quietly Recasting Its Gene Therapy Moat With New HiPer Viral Vector Resins? - simplywall.st
Riverbridge Partners LLC Sells 24,644 Shares of Repligen Corporation $RGEN - MarketBeat
Congress Asset Management Co. Boosts Stake in Repligen Corporation $RGEN - Defense World
Assenagon Asset Management S.A. Takes Position in Repligen Corporation $RGEN - MarketBeat
Can Repligen Corporation stock maintain growth trajectoryFed Meeting & Smart Allocation Stock Tips - Улправда
Texas Permanent School Fund Corp Has $3.13 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Will Repligen Corporation stock rally after Fed decisions2025 Winners & Losers & Free Technical Pattern Based Buy Signals - Улправда
Why Repligen Corporation (RGN) stock trades below fair valueJuly 2025 Drop Watch & Risk Managed Investment Signals - Bölüm Sonu Canavarı
Repligen (RGEN): Assessing Valuation After New Chromatography Resins Expand Its Gene Therapy Toolkit - simplywall.st
6.80%
자본화:
|
볼륨(24시간):